Indole-based hydrazide-hydrazone and sulfonylhydrazone derivatives as MAO-B inhibitors with multitarget potential for neurodegenerative diseases

Magdalena Kondeva-Burdina, Kaloyan Krastev, Tania Pencheva, Violina T. Angelova

Open source

DOI: 10.3897/pharmacia.72.e155372
Published: 2025-06-17
Container: Pharmacia
Publisher: Pensoft Publishers
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3897/pharmacia.72.e155372,
  title = {Indole-based hydrazide-hydrazone and sulfonylhydrazone derivatives as MAO-B inhibitors with multitarget potential for neurodegenerative diseases},
  author = {Magdalena Kondeva-Burdina and Kaloyan Krastev and Tania Pencheva and Violina T. Angelova},
  year = {2025},
  journal = {Pharmacia},
  doi = {10.3897/pharmacia.72.e155372},
  url = {https://doi.org/10.3897/pharmacia.72.e155372}
}

RIS

TY  - JOUR
TI  - Indole-based hydrazide-hydrazone and sulfonylhydrazone derivatives as MAO-B inhibitors with multitarget potential for neurodegenerative diseases
AU  - Magdalena Kondeva-Burdina
AU  - Kaloyan Krastev
AU  - Tania Pencheva
AU  - Violina T. Angelova
PY  - 2025
JO  - Pharmacia
DO  - 10.3897/pharmacia.72.e155372
UR  - https://doi.org/10.3897/pharmacia.72.e155372
ER  -

APA

Kondeva-Burdina, M., Krastev, K., Pencheva, T., & Angelova, V. T. (2025). Indole-based hydrazide-hydrazone and sulfonylhydrazone derivatives as MAO-B inhibitors with multitarget potential for neurodegenerative diseases. Pharmacia. https://doi.org/10.3897/pharmacia.72.e155372

Source records

crossref · retrieved 2026-11-05T18:59:26.797Z